Categories: Life Science | Format :
MARKET DEFINITION
Semi-solid refers to a substance that comprises both solid and liquid components. Semisolid dose forms comprise both solid and liquid components. These dose formulations are vicious by nature. Often used topically or externally. Semisolid dosage forms are topical dosage forms that are utilized for medicinal, protective, or cosmetic purposes. It can be administered to the skin, nasal cavity, vaginal cavity, or rectal cavity. Creams, ointments, gels, transdermal patches, and suppositories are all examples of semi-solids. Merck's knowledge and support enable us to provide you with a chosen range of actives and auxiliaries. The majority of semi-solid dose (SSD) form product administration routes are topical or involve inserting the medication product into a bodily opening.
MARKET DYNAMICS
The rise in the prevalence of skin illnesses worldwide as a result of global warming factors is attributed to the growth of the Semi-Solid Dosage Form Market. Furthermore, the site-specific action of the administered medicine as the process of healing will only occur at the location where it is applied is one of the primary drivers for the market. Furthermore, dosage forms lower the risk of medication potency loss due to first-pass metabolism in the human body is a major driver for this market. However, irritations and allergies at the site are likely to hamper the market growth. Moreover, rising innovation and significant investments will create a lucrative opportunity.
REPORT SCOPE
The report titled “Global Semi-Solid Dosage Form Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Semi-Solid Dosage Form market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Semi-Solid Dosage Form market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Semi-Solid Dosage Form Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.
GEOGRAPHICAL OVERVIEW
The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.
MARKET SEGMENTATION
The Global Semi-Solid Dosage Form Market is segmented based on product type, ingredient type, application, end-user, and region. Based on product type, the market has been segmented into Ointments, Pastes, Cream, Plasters, Gels, and Rigid Foams, whereas based on ingredient type, the market comprises Bases, Preservative, Humectants, Antioxidants, Emulsifier, Gelling agent, Permeation enhancer, and Buffers. Based on application, the market has been segmented into Skin, Nasal Cavity, Vaginal Cavity, Rectal Cavity, and Others, whereas, the end-user segmentation includes Hospitals and Clinics, Ambulatory Surgical Centers, and Others.
COMPETITION LANDSCAPE
The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Semi-Solid Dosage Form market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Semi-Solid Dosage Form market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Semi-Solid Dosage Form market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Semi-Solid Dosage Form industry in the past three years.
Key players in the Global Semi-Solid Dosage Form Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:
COVID-19 IMPACT ANALYSIS ON GLOBAL SEMI-SOLID DOSAGE FORM MARKET
The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.
In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.
Report Attribute/Metric |
Details |
Market Size |
In USD Million |
CAGR |
In % (2022-2028) |
Base Year |
2021 |
Forecast Period |
2022 – 2028 |
Historical Data |
2017 to 2021 |
Forecast Unit |
Value (US$ Mn) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors and Trends |
Geographies Covered |
North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
Key Players Analyzed |
Johnson & Johnson, Merck & Co, Bayer AG, Glenmark Pharmaceuticals, Cipla Ltd, Novartis AG, GlaxoSmithKline plc, Bausch Health Companies, Allergan plc, Biofrontera, Inc., Crown Laboratories Inc., Akorn Inc., Ingenus Pharmaceuticals, and Sun Pharmaceuticals |
Customization & Pricing |
Available on Request (10% Customization is Free) |
RESEARCH PROGRAM DESIGN
KEY QUESTIONS ANSWERED
REASONS FOR BUYING THIS REPORT:
Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Application
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Product Type Trends
3.2.2. Ingredient Type Trends
3.2.3. Application Trends
3.2.4. End-user Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Semi-Solid Dosage Form Market
3.6. COVID-19 Impact Assessment in Semi-Solid Dosage Form Market
3.6.1. Impact Assessment on Global Semi-Solid Dosage Form Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape
Chapter 4. Global Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
4.1. Global Semi-Solid Dosage Form Market Share, By Product Type, 2017 - 2028 (USD Million)
4.1.1. Ointments
4.1.2. Pastes
4.1.3. Cream
4.1.4. Plasters
4.1.5. Gels
4.1.6. Rigid Foams
Chapter 5. Global Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
5.1. Global Semi-Solid Dosage Form Market Share, By Ingredient Type, 2017 - 2028 (USD Million)
5.1.1. Bases
5.1.2. Preservative
5.1.3. Humectants
5.1.4. Antioxidants
5.1.5. Emulsifier
5.1.6. Gelling agent
5.1.7. Permeation enhancer
5.1.8. Buffers
Chapter 6. Global Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
6.1. Global Semi-Solid Dosage Form Market Share, By Application, 2017 - 2028 (USD Million)
6.1.1. Skin
6.1.2. Nasal Cavity
6.1.3. Vaginal Cavity
6.1.4. Rectal Cavity
6.1.5. Others
Chapter 7. Global Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
7.1. Global Semi-Solid Dosage Form Market Share, By End-user, 2017 - 2028 (USD Million)
7.1.1. Hospitals and Clinics
7.1.2. Ambulatory Surgical Centers
7.1.3. Others
Chapter 8. Global Semi-Solid Dosage Form Market Overview, By Geography, 2017 - 2028 (USD Million)
8.1. Global Semi-Solid Dosage Form Market Share, By Geography, 2017 - 2028 (USD Million)
8.1.1. Market Ingredient Type and Projections, by Countries, 2017 - 2028 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)
Chapter 9. North America Semi-Solid Dosage Form Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. North America Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market Ingredient Type and projections, 2017 - 2028 (USD Million)
9.1.2. North America Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
9.1.3. North America Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
9.1.4. North America Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
9.1.5. North America Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
9.2. North America Semi-Solid Dosage Form Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. U.S. Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. U.S. Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
9.2.1.2. U.S. Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
9.2.1.3. U.S. Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.1.4. U.S. Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
9.2.2. Canada Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. Canada Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
9.2.2.2. Canada Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
9.2.2.3. Canada Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.2.4. Canada Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
9.2.3. Mexico Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. Mexico Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
9.2.3.2. Mexico Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
9.2.3.3. Mexico Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.3.4. Mexico Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
Chapter 10. Europe Semi-Solid Dosage Form Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. Europe Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market Ingredient Type and projections, 2017 - 2028 (USD Million)
10.1.2. Europe Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
10.1.3. Europe Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
10.1.4. Europe Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
10.1.5. Europe Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2. Europe Semi-Solid Dosage Form Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. Germany Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. Germany Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
10.2.1.2. Germany Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
10.2.1.3. Germany Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.1.4. Germany Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.2. France Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. France Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
10.2.2.2. France Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
10.2.2.3. France Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.2.4. France Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.3. UK Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. UK Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
10.2.3.2. UK Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
10.2.3.3. UK Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.3.4. UK Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.4. Italy Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
10.2.4.1. Italy Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
10.2.4.2. Italy Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
10.2.4.3. Italy Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.4.4. Italy Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.5. Spain Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
10.2.5.1. Spain Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
10.2.5.2. Spain Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
10.2.5.3. Spain Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.5.4. Spain Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.6. NORDIC Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
10.2.6.1. NORDIC Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
10.2.6.2. NORDIC Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
10.2.6.3. NORDIC Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.6.4. NORDIC Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.7. Russia and CIS Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
10.2.7.1. Russia and CIS Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
10.2.7.2. Russia and CIS Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
10.2.7.3. Russia and CIS Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.7.4. Russia and CIS Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.8. Rest of Europe Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
10.2.8.1. Rest of Europe Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
10.2.8.2. Rest of Europe Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
10.2.8.3. Rest of Europe Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.8.4. Rest of Europe Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
Chapter 11. Asia Pacific Semi-Solid Dosage Form Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. Asia Pacific Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market Ingredient Type and projections, 2017 - 2028 (USD Million)
11.1.2. Asia Pacific Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
11.1.3. Asia Pacific Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
11.1.4. Asia Pacific Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
11.1.5. Asia Pacific Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
11.2. Asia Pacific Semi-Solid Dosage Form Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. India Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. India Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
11.2.1.2. India Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
11.2.1.3. India Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.1.4. India Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
11.2.2. China Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. China Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
11.2.2.2. China Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
11.2.2.3. China Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.2.4. China Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
11.2.3. Japan Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Japan Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
11.2.3.2. Japan Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
11.2.3.3. Japan Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.3.4. Japan Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
11.2.4. ASEAN Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
11.2.4.1. ASEAN Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
11.2.4.2. ASEAN Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
11.2.4.3. ASEAN Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.4.4. ASEAN Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
11.2.5. South Korea Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
11.2.5.1. South Korea Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
11.2.5.2. South Korea Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
11.2.5.3. South Korea Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.5.4. South Korea Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
11.2.6. Australia Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
11.2.6.1. Australia Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
11.2.6.2. Australia Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
11.2.6.3. Australia Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.6.4. Australia Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
11.2.7. Rest of Asia Pacific Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
11.2.7.1. Rest of Asia Pacific Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
11.2.7.2. Rest of Asia Pacific Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
11.2.7.3. Rest of Asia Pacific Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.7.4. Rest of Asia Pacific Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
Chapter 12. South America Semi-Solid Dosage Form Market Overview, By Countries, 2017 - 2028 (USD Million)
12.1. South America Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
12.1.1. Market Ingredient Type and projections, 2017 - 2028 (USD Million)
12.1.2. South America Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
12.1.3. South America Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
12.1.4. South America Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
12.1.5. South America Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
12.2. South America Semi-Solid Dosage Form Market Overview, By Countries, 2017 - 2028 (USD Million)
12.2.1. Brazil Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
12.2.1.1. Brazil Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
12.2.1.2. Brazil Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
12.2.1.3. Brazil Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.1.4. Brazil Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
12.2.2. Argentina Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
12.2.2.1. Argentina Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
12.2.2.2. Argentina Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
12.2.2.3. Argentina Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.2.4. Argentina Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
12.2.3. Rest of South America Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
12.2.3.1. Rest of South America Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
12.2.3.2. Rest of South America Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
12.2.3.3. Rest of South America Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.3.4. Rest of South America Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
Chapter 13. Middle East & Africa Semi-Solid Dosage Form Market Overview, By Countries, 2017 - 2028 (USD Million)
13.1. Middle East & Africa Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
13.1.1. Market Ingredient Type and projections, 2017 - 2028 (USD Million)
13.1.2. Middle East & Africa Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
13.1.3. Middle East & Africa Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
13.1.4. Middle East & Africa Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
13.1.5. Middle East & Africa Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
13.2. Middle East & Africa Semi-Solid Dosage Form Market Overview, By Countries, 2017 - 2028 (USD Million)
13.2.1. GCC Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
13.2.1.1. GCC Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
13.2.1.2. GCC Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
13.2.1.3. GCC Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
13.2.1.4. GCC Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
13.2.2. South Africa Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
13.2.2.1. South Africa Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
13.2.2.2. South Africa Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
13.2.2.3. South Africa Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
13.2.2.4. South Africa Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
13.2.3. Rest of Middle East & Africa Semi-Solid Dosage Form Market Overview, 2017 - 2028 (USD Million)
13.2.3.1. Rest of Middle East & Africa Semi-Solid Dosage Form Market Overview, By Product Type, 2017 - 2028 (USD Million)
13.2.3.2. Rest of Middle East & Africa Semi-Solid Dosage Form Market Overview, By Ingredient Type, 2017 - 2028 (USD Million)
13.2.3.3. Rest of Middle East & Africa Semi-Solid Dosage Form Market Overview, By Application, 2017 - 2028 (USD Million)
13.2.3.4. Rest of Middle East & Africa Semi-Solid Dosage Form Market Overview, By End-user, 2017 - 2028 (USD Million)
Chapter 14. Competitive Landscape
14.1. Competitive Environment, 2021
14.2. Strategic Framework
14.2.1. Partnership/Collaborations/Agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Product Development
Chapter 15. Key Vendor Analysis
15.1. Johnson & Johnson
15.1.1. Business Overview
15.1.2. Product Benchmarking
15.1.3. Financial Data
15.1.4. Strategic Overview
15.1.5. Key Developments
15.1.6. SWOT Analysis
15.2. Merck & Co
15.2.1. Business Overview
15.2.2. Product Benchmarking
15.2.3. Financial Data
15.2.4. Strategic Overview
15.2.5. Key Developments
15.2.6. SWOT Analysis
15.3. Bayer AG
15.3.1. Business Overview
15.3.2. Product Benchmarking
15.3.3. Financial Data
15.3.4. Strategic Overview
15.3.5. Key Developments
15.3.6. SWOT Analysis
15.4. Glenmark Pharmaceuticals
15.4.1. Business Overview
15.4.2. Product Benchmarking
15.4.3. Financial Data
15.4.4. Strategic Overview
15.4.5. Key Developments
15.4.6. SWOT Analysis
15.5. Cipla Ltd
15.5.1. Business Overview
15.5.2. Product Benchmarking
15.5.3. Financial Data
15.5.4. Strategic Overview
15.5.5. Key Developments
15.5.6. SWOT Analysis
15.6. Novartis AG
15.6.1. Business Overview
15.6.2. Product Benchmarking
15.6.3. Financial Data
15.6.4. Strategic Overview
15.6.5. Key Developments
15.6.6. SWOT Analysis
15.7. GlaxoSmithKline plc
15.7.1. Business Overview
15.7.2. Product Benchmarking
15.7.3. Financial Data
15.7.4. Strategic Overview
15.7.5. Key Developments
15.7.6. SWOT Analysis
15.8. Bausch Health Companies
15.8.1. Business Overview
15.8.2. Product Benchmarking
15.8.3. Financial Data
15.8.4. Strategic Overview
15.8.5. Key Developments
15.8.6. SWOT Analysis
15.9. Allergan plc
15.9.1. Business Overview
15.9.2. Product Benchmarking
15.9.3. Financial Data
15.9.4. Strategic Overview
15.9.5. Key Developments
15.9.6. SWOT Analysis
15.10. Biofrontera, Inc.
15.10.1. Business Overview
15.10.2. Product Benchmarking
15.10.3. Financial Data
15.10.4. Strategic Overview
15.10.5. Key Developments
15.10.6. SWOT Analysis
15.11. Crown Laboratories Inc.
15.11.1. Business Overview
15.11.2. Product Benchmarking
15.11.3. Financial Data
15.11.4. Strategic Overview
15.11.5. Key Developments
15.11.6. SWOT Analysis
15.12. Akorn Inc.
15.12.1. Business Overview
15.12.2. Product Benchmarking
15.12.3. Financial Data
15.12.4. Strategic Overview
15.12.5. Key Developments
15.12.6. SWOT Analysis
15.13. Ingenus Pharmaceuticals
15.13.1. Business Overview
15.13.2. Product Benchmarking
15.13.3. Financial Data
15.13.4. Strategic Overview
15.13.5. Key Developments
15.13.6. SWOT Analysis
15.14. Sun Pharmaceuticals
15.14.1. Business Overview
15.14.2. Product Benchmarking
15.14.3. Financial Data
15.14.4. Strategic Overview
15.14.5. Key Developments
15.14.6. SWOT Analysis
Chapter 16. Future Outlook of the Market
Disclaimer
Published On:Nov-22
Base Year:2021
Historical Data:2019-2020
No of Pages:250
Semi-Solid Dosage Form Market Growth, Trends, and ...
RD Code : HP22